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ABSTRACT
Autoimmune hepatitis (AIH) is described as T lymphocyte suppressor disturbance, thus there is formation of 
autoantibody which attacks surface antigen of liver cells or hepatocytes. Diagnosis of AIH is done after other 
liver abnormalities have been ruled out. The diagnosis of AIH needs to be done with thorough and careful 
examination as there is no pathognomonic clinical appearance.
A 22-year-old male patient was referred to Saiful Anwar Hospital because of liver dysfunction with increased 
serum levels of aspartate transaminase (AST) 757 U/L and alanine transaminase (ALT) 345 U/L. Histological 
findings after liver biopsy were compatible to AIH. He was formerly admitted to a nearby hospital two months 
ago and diagnosed with acute viral hepatitis, but his transaminase serum level remains elevated. He had 
negative hepatitis viral marker, hypergammaglobulinemia, and liver biopsy compatible to AIH. Calculation 
using International Autoimmune Hepatitis Group (IAIHG) scoring from the American Association for the Study 
of Liver Disease (AASLD) 2010 showed result of probable diagnosed autoimmune hepatitis. Treatment with 
methylprednisolone 16 mg once daily and hepatoprotector resulted in decreased transaminase serum level and 
clinical improvement.
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ABSTRAK 
Hepatitis autoimun digambarkan sebagai gangguan supresor limfosit T sehingga terbentuk autoantibodi 
yang menyerang antigen pada permukaan sel hepar atau hepatosit. Diagnosis hepatitis autoimun merupakan 
diagnosis setelah penyebab kelainan hati lain disingkirkan. Penegakan diagnosis hepatitis autoimun memerlukan 
pemeriksaan yang cermat dan seksama karena gambaran klinis yang tidak patognomonis.
Seorang pasien laki-laki usia 22 tahun dirujuk ke Rumah Sakit Saiful Anwar karena disfungsi hati dengan 
peningkatan kadar serum transaminase, AST 757 IU/L dan ALT 345 IU/L. Hasil temuan histologis setelah 
biopsi hati menunjukkan kesesuaian dengan hepatitis autoimun. Pasien sebelumnya dirawat di rumah sakit dua 
bulan yang lalu dan didiagnosis hepatitis akut, akan tetapi kadar serum transaminase terus meningkat. Hasil 
pemeriksaan seromarker hepatitis negatif, dengan hipergammaglobulinemia dan biopsi hati yang sesuai dengan 
hepatitis autoimun. Penegakan diagnosis dengan sistem skoring International Autoimmune Hepatitis Group 
dari the American Association for the Study of Liver Disease (AASLD) 2010 juga menunjukkan kemungkinan 
diagnosis autoimun hepatitis. Pengobatan dengan metilprednisolon oral 16 mg perhari dan hepatoprotektor 
menghasilkan penurunan kadar serum transaminase dan perbaikan gejala klinis. 
Kata kunci: hepatitis autoimun, asimptomatis, peningkatan serum transaminase menetap
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INTRODUCTION
Autoimmune hepatitis (AIH), is an inflammation of 
the liver with unknown etiology.1 Autoimmune hepatitis 
is described as T lymphocyte suppressor disturbance, 
thus there is formation of autoantibody which attacks 
surface antigen of liver cells or hepatocytes, causing 
progressive necroinflammation or if continues may 
develop into fibrosis process in liver cells.2
Autoimmune hepatitis is more dominant in young 
age with the comparison of female to male 3.6 : 1, 
and may happen in all ethnic. Epidemiology data 
in Norway and Sweden revealed that the average 
incidence of autoimmune hepatitis is 1-2 cases per 
100,000 population per year, with prevalence of 11-17 
incidence per 100,000 population per year.3,4 As much 
as 25% incidence of autoimmune hepatitis manifest as 
acute hepatitis and signs of other autoimmune diseases, 
including fever, malaise, urticaria rash, poliarthritis, or 
glomerulonephritis, most others are asymptomatic and 
known during the appearance of chronic liver disease.5,6
Diagnosis of autoimmune hepatitis is a diagnosis 
after other liver abnormalities have been ruled out, 
because no pathognomonic appearance or specific 
laboratory test is found. In the American Association for 
the Study of Liver Disease (AASLD) practice guideline 
2010, diagnosis of autoimmune hepatitis is based 
on abnormal liver histology, clinical characteristics, 
abnormal globulin serum level, and presence of one 
or more autoantibody.8-12 The background of this 
case report is problem in establishing the diagnosis 
of autoimmune hepatitis due to not pathognomonic 
clinical appearance, thus thorough and careful 
examination is needed. 
CASE ILLUSTRATION
A 22 year old male visited Division of Gastroentero-
hepatology, Department of Internal Medicine, Saiful 
Anwar Hospital, Malang, with chief complaint of 
easily fatigue after activity since approximately two 
months. Two months before, patient complained of 
fever, nausea and vomiting and body weakness after 
strenuous acitivity. Patient has been hospitalized 
for a week and diagnosed with acute hepatitis in 
a private hospital in Jakarta. However, after two 
months patient still complained of body weakness 
after strenuous activity and continuous increase of 
aspartate transaminase (AST) and alanine transaminase 
(ALT). History of treatment in patient include the 
administration of hepatoprotector tablet once daily for 
two months, no history of past illness and history of 
familial hepatitis; furthermore, patient often had high 
level of transaminase level since the last 6 months.
Physical examination resulted looked moderately 
ill, body height 173 cm, body weight 70 kg. Blood 
pressure 110/70 mmHg, heart rate 67 bpm, respiratory 
rate 16 bpm, temperature 36.8ºC. There was no signs 
of anemic, icteric, cyanosis or even edema. Liver and 
spleen examination were normal, normal bowel sound. 
From laboratory examination, results of complete 
blood count were hemoglobin 16.9 g/dL, leukocyte 
7,500/uL, thrombocyte 333,000/uL. Results of kidney 
function tests were urea 19.70 mg/dL, creatinine 0.94 
mg/dL. Liver function and hemostasis revealed alanin 
transaminase (ALT) 122 U/L, aspartate transaminase 
(AST) 256 U/L, partial thromboplastin time (PTT) = 9.7 
seconds (control = 11.1-11.6 seconds), activated PTT 
(APTT) = 31.4 seconds (control = 28.9-30.6 seconds), 
total bilirubin = 0.94 mg/dL, direct bilirubin = 0.60 mg/
dL, indirect bilirubin = 0.34 mg/dL, alkali phosphatase 
= 122 U/L, gamma globulin = 117 U/L, albumin = 4.91 
U/L. For hepatitis marker: HBsAg (negative index S/
CO) = 0.329; anti HAV IgM (negative index) = 0.329, 
anti HCV (negative S/CO) = 0.074. Autoantibody 
examinations resulted negative antinuclear antibody 
(ANA) test, protein electrophoresis (γ-Globulin) 
showed hipergammaglobulinemia (3.16 g/dL). From 
results of abdominal ultrasound, there was no sign of 
inflammation or other pathological condition in the 
abdomen.
AST changes in patient were 245 U/L, 757 U/L, 
and 246 U/L respectively in three laboratory test a 
month before admission to Saiful Anwar Hospital. 
ALT levels were 757 U/L, 394 U/L, and 116 U/L 
respectively, also gamma GT 69.7 U/L and 111 U/L 
in two previous examinations. Patient was only given 
hepatoprotector which was administered once daily. 
In the second day of hospitalization liver biopsy was 
performed to the patient with obtained results as shown 
in Figure 1 and 2. 
Figure 1. Appearance of hepatocytes showing ballooning changes and 
Kuppferprominent cell (spindle cell), and rosette at 200x magnification
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Figure 2. Appearance of inflammatory limphoplasmatic cell 
infiltrate in portal track and lymphocyte infiltrate in lobular 
centro at 400x magnification
autoimmune hepatitis diagnosis can use scoring system 
of IAHG (class IIA, level B).9 Patient score 12 was 
concluded probable diagnosis, so it was still possible 
that this patient suffered from autoimmune hepatitis, 
regardless the presence of other autoimmune disease.
Several autoimmune hepatitis case reports including 
in 2011, in a 58 year old female with Graves disease, 
initially it was suspected as propil tiouracil (PTU)-
associated hepatitis, but biopsy results showed 
plasma cell infiltration and rosette appearance in liver 
tissue and negative hepatitis marker, with scoring the 
diagnosis of autoimmune hepatitis was established; 
further, there was improvement with steroid therapy.17 
A case series by Sally et al, showed 3 cases in 
Caucasian female aged 42, 65, and 74 years old which 
exhibited spectrum and clinical complaints like patient 
in this case report, particularly unspecific complaints 
and normal abdominal USG, but liver biopsy revealed 
inflammatory cells and plasma cells infiltration.18 
In those three cases, there was report on long-
term nitrofurantoin for the prophylaxis of recurrent 
urinary tract infection, which was suspected to have 
role in the incidence of autoimmune hepatitis; all three 
showed clinical improvement after corticosteroid 
administration, similar to the case we reported.
Based on AASLD scoring, from data of patient's 
examination, it was obtained ratio of alkali phosphatase 
and AST < 1.5 U/L (score 2), gamma globulin level 
1.5 - 2 times normal level (score 2), negative hepatitis 
virus marker (A, B, C) (score 3), no history of drugs 
consumption (score 1), daily alcohol consumption < 
25 g/day (score 2), histopathological appearance of 
liver biopsy showed rosette formation and plasma cell 
infiltration (score 2).
Patient was given supportive therapy, bedrest and 
high calorie and protein per oral diet, and corticosteroid 
therapy (metilprednisolone 16 mg once daily per oral) 
and hepatoprotector 1 mg daily, with corticosteroid side 
effect monitoring. Good result was obtained, in the form 
of clinical symptoms improvement and transaminase 
level decrease, in day-3, there was decrease of AST 256 
U/L, ALT 84 U/L, and evaluation on hospitalization 
day-7, there was decrease of AST 105 U/L and ALT 
60 U/L, with improvement complaints in knowledge 
representation syntax (KRS) for treatment through 
outpatient ward.
Data from randomized controled trial (RCT) 
showed prednisone as single agent or in combination 
with azathioprine resulted in symptoms improvement, 
laboratory results improvement, histopathology and 
survival rate improvement. While, liver transplantation 
Based on clinical evaluation, laboratory, 
histopathology (rosette appearance and plasma cell 
infiltration) and negative hepatitis marker, patient was 
diagnosed with autoimmune hepatitis based on AASLD 
practice guideline 2010; was given hepatoprotector 
and corticosteroid which resulted in improvement of 
transaminase level.
DISCUSSION
In this patient, from anamnesis and physical 
examination there was no specific appearance, but there 
was persistent increase in serum transaminase, increase 
protein electrophoresis results, negative hepatitis A, B, 
and C result, also liver biopsy result showed plasma 
cell infiltration and rosettes appearance; this finding 
could support autoimmune hepatitis description, based 
on AASLD practice guideline 2010 (class I, level B).9
Based on autoimmune hepatitis diagnosis criteria 
according AASLD practice guideline 2010, in this 
patient there was negative marker hepatitis, either 
hepatitis A, B, or C. Daily alcohol consumption 
was < 25 g/day, laboratory results showed gamma 
globulin level > 1.5 times from normal cut off. 
Regarding autoantibody marker, ANA test was 
performed and showed normal result. Anti liver kidney 
microsomal (LKM)-1 and α1-antitripsin test was mot 
performed because of facility limitation. Appearance 
in histopathology of liver biopsy in the form of plasma 
cell infiltration and rosette appearance in liver cells, 
can support diagnosis of autoimmune hepatitis. 
Based on AASLD practice guideline 2010 about 
autoimmune hepatitis, in 2 recommendations, it is stated 
that if clinical appearance and laboratory, serology 
and histopathology are not spesific, establishment of 
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is definitive therapy in patient who experienced acute 
liver failure and in patient who already suffer from 
decompensated liver function. In condition if there 
is decompensated cirrhosis with model for end-stage 
liver disease (MELD) score > 15, and hepatocellular 
carcinoma appearance.13-16 Clinicians need to be 
cautious in the possibility of autoimmune hepatitis in 
young patients with unspecific symptoms, increase 
serum transaminase level, and negative hepatitis virus 
marker examination (A, B, dan C). 
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